Replies to post #28212 on Humanigen Inc (fka HGENQ)

[CJames22]

There is precedent for approval after phase 2 in CAR-T. Given the promising results so far with Lenz w/r/t efficacy and, most importantly, safety, I would not be surprised to see an excellent P2 study and approval based on that